NextCure  Inc (NXTC)

NextCure  Inc (NXTC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $24.9M; returns 1 day +5.5%, 1 week -20.2%, 1 year -44.0%.

NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical company focused on developing novel immunomedicines for cancer treatment by targeting immunosuppressive mechanisms in the tumor microenvironment. The company has no commercialized products and generates minimal to no revenue, relying primarily on cash reserves, equity financings, and occasional collaboration agreements for funding.

Groups NXTC belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Biopharmaceutical
• Immunotherapy
• Clinical Stage
• Cancer Therapeutics
• Antibody Therapeutics
• R&D
• Drug Discovery

NXTC financial model: income statement, cash flow and balance sheet